Connect to MCP

Claude DesktopClaude Code (CLI)ChatGPTCursorVS Code

Enlitic Valuation Multiples

Discover Enlitic's revenue and EBITDA valuation multiples and M&A history.

Start Free TrialSee companies similar to Enlitic

Enlitic Overview

About Enlitic

Enlitic Inc is the AI-enabled healthcare revolution. The company has developed an intelligent data framework that powers critical workflows, orchestrates data, and enables greater comprehension of what information resides in archives thereby unlocking new revenue opportunities, generating cost savings, and improving healthcare delivery. It provides solutions for Radiologists, IT Professionals, Executives, and Researchers. The Group has two operating segments: Software includes intelligently managing healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows, etc; and Migration services Transfer large volumes of imaging data to allow for the smooth transition of software solutions for healthcare vendors and providers and Migration services.

Founded

2014

HQ

United States

Employees

N/A

Financials (FY)

Revenue: $4M
EBITDA: ($13M)

EV

$18M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Enlitic Financials

Enlitic reported last fiscal year revenue of $4M and negative EBITDA of ($13M).

In the same fiscal year, Enlitic generated $4M in gross profit, ($13M) in EBITDA losses, and had net loss of ($13M).

Enlitic P&L

In the most recent fiscal year, Enlitic reported revenue of $4M and EBITDA of ($13M).

Enlitic is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (333%), and net margin of (352%).

See analyst estimates for Enlitic
Last FY202320242025202620272028
Revenue$4M$496K$1M$4M
Gross Profit$4M$496K$1M$4M
Gross Margin100%100%100%100%
EBITDA($13M)($15M)($15M)($13M)
EBITDA Margin(333%)(3045%)(1399%)(333%)
EBIT Margin(352%)(3137%)(1473%)(352%)
Net Profit($13M)($16M)($15M)($13M)
Net Margin(352%)(3136%)(1412%)(352%)

Financial data powered by Morningstar, Inc.

Enlitic Stock Performance

Enlitic has current market cap of $20M, and enterprise value of $18M.

Enlitic's stock price is $0.00.

See more trading valuation data for Enlitic
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$18M$20M-0.0%---$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Enlitic Valuation Multiples

Enlitic trades at 4.8x EV/Revenue multiple, and (1.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Enlitic

Enlitic Financial Valuation Multiples

As of August 14, 2026, Enlitic has market cap of $20M and EV of $18M.

Enlitic has a P/E ratio of (1.5x).

Last FY202320242025202620272028
EV/Revenue4.8x37.0x17.0x4.8x
EV/EBITDA(1.5x)(1.2x)(1.2x)(1.5x)
EV/EBIT(1.4x)(1.2x)(1.2x)(1.4x)
EV/Gross Profit4.8x37.0x17.0x4.8x
P/E(1.5x)(1.3x)(1.3x)(1.5x)
EV/FCF(1.6x)(1.2x)(1.2x)(1.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Enlitic Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Enlitic Margins & Growth Rates

In the most recent fiscal year, Enlitic reported gross margin of 100%, EBITDA margin of (333%), and net margin of (352%).

See estimated margins and future growth rates for Enlitic

Enlitic Margins

Last FY20242025202720282029
Gross Margin100%100%100%
EBITDA Margin(333%)(1399%)(333%)
EBIT Margin(352%)(1473%)(352%)
Net Margin(352%)(1412%)(352%)
FCF Margin(311%)(1408%)(311%)

Enlitic Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth118%252%
Gross Profit Growth118%252%
EBITDA Growth(0%)(16%)
EBIT Growth2%(16%)
Net Profit Growth(2%)(12%)
FCF Growth2%(22%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Enlitic Operational KPIs

Access forward-looking KPIs for Enlitic
Last FY202320242025202620272028
S&M Expenses to Revenue7%53%36%7%
G&A Expenses to Revenue314%1800%910%314%
Opex to Revenue452%3237%1573%452%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Digital TherapeuticsHorizontal MarketplacesInvestment BankingERP SoftwareDeveloper ToolsConsumer SaaSStreamingVertical SaaSNetworking HardwareFinancial Data & InformationEnergy StorageRoad InfrastructureSemiconductors
Explore Valuation Multiples by Industry

Enlitic Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Enlitic competitors and their valuation data.

Start Free Trial

Enlitic VC Funding History

Before going public, Enlitic raised $69M in total equity funding, across 5 rounds.

Last private valuation of Enlitic was $62M, after raising $14M in December 2023.

Enlitic Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Dec-23Undisclosed stage-$14M$62MEnlitic develops AI software for radiology, including ENDEX for medical imaging data indexing and ENCOG for cognitive analysis, positioning itself with no direct competitors in the healthcare IT radiology sub-sector targeting the US$3.7bn market. In December 2023, Enlitic sought to list on the ASX via IPO, aiming to raise A$20-35M at 83 cents per CDI for an indicative market cap of A$106-133M (US$70.5-85.5M), with the offer closing December 5, 2023. Funds were earmarked for sales, marketing, product development, R&D, regulatory compliance, and working capital. FY23 revenue stood at US$645,000, supported by a US$96.7M pipeline across 118 opportunities. Clients included Europe's TMC (over 1M annual reports), Japan's Marubeni, UK's Multi Inc, and US providers Sentara Health and SEARHC.
Nov-19Series BCapitol Health; Amplify Partners; Regal Investment Fund; Marubeni; Thorney Opportunities; The Jagen Group$25M-Enlitic is an artificial intelligence software developer focused on medical imaging, building an AI platform to streamline workflows for radiologists and improve diagnostics. The company raised $25 million in a Series B-II funding round on November 14, 2019, led by Thorney Opportunities (also referred to as Thorney Investment Group), with participation from Amplify Partners, Capitol Health, Marubeni Corporation, The Jagen Group, and Regal Funds Management (Regal Investment Fund). This round brought Enlitic's total funding to $55 million across multiple rounds. The funds were intended to support the continued development and release of Enlitic's AI platform, planned for 2020, with a showcase at RSNA 2019 in December. Additionally, Lawrence Gozlan from The Jagen Group joined Enlitic's board of directors as part of the round. Enlitic's solutions aim to manage healthcare data intelligently, expanding capacity and enhancing clinical workflows.
Apr-19Series BCapitol Health; Alium Capital; Marubeni$15M-Enlitic is a San Francisco-based artificial intelligence software company focused on medical imaging analysis, specifically helping radiologists interpret X-rays and other diagnostic images more quickly and accurately. The company uses AI to streamline medical imaging workflows across radiography, CT scanning, and MRI analysis. In April 2019, Enlitic closed a $15 million Series B funding round led by Japanese trading company Marubeni, with participation from existing investors Capitol Health and others. The investment came as part of a strategic partnership with Marubeni to develop and distribute Enlitic's products in Japan and Asia, where aging populations and shrinking workforces create heightened demand for diagnostic imaging efficiency. By early 2019, Enlitic had set ambitious product development targets, aiming to interpret 95% of all X-ray types by end of 2019 and common CT and MRI scans by 2021. The company was pursuing regulatory approval from the FDA, Australian authorities, and other international regulators, with a focus on clinical deployment in the U.S., Australia, Brazil, Canada, Europe, and Japan. Proceeds from the Series B were allocated toward enhancing the AI platform, expanding engineering and data science teams, pursuing regulatory clearances, and establishing a new processing center in Washington state that opened in January 2019.
Oct-15Series BCapitol Health; Mission and Market; Amplify Partners; DCVC$10M-Enlitic, a deep learning medical imaging company, raised $10 million in Series B funding on October 28, 2015, led by Capitol Health Limited with participation from other investors. The funding supported partnership with Capitol Health to commercialize Enlitic’s technology in Australia, New Zealand, and Asia, providing marketing rights and integrating deep learning tools into radiology workflows. Capitol committed up to USD$10 million investment, enabling radiologists to participate. Enlitic's technology enhances diagnostic accuracy by over 50% and speeds up analysis 50,000 times faster than manual reads, leveraging Capitol’s image archives across modalities like CT, MRI, and X-ray. The company was selected by MIT Technology Review as one of the world's 50 Smartest Companies in 2015. This round advanced tools for diseases from lung cancer to bone fractures, aiming to map the entire human body.
Oct-14SeedSeven Peaks Ventures; Amplify Partners; DCVC$5M--

Acquisitions by Enlitic

Enlitic has acquired 1 company to date.

Last acquisition by Enlitic was on October 17th 2024. Enlitic acquired Laitek for $5M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Enlitic

Laitek
Description
Laitek is a Helsinki-based developer of software solutions for capturing, processing, and visualizing medical and scientific images in radiology, pathology, and research applications. The company's platforms integrate with PACS systems and support AI-enhanced diagnostics for healthcare providers worldwide.
HQ CountryUnited States
HQ City
Huntsville, AL
Deal Date17 Oct 2024
Valuation$5M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Enlitic acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Enlitic

When was Enlitic founded?Enlitic was founded in 2014.
Where is Enlitic headquartered?Enlitic is headquartered in United States.
Is Enlitic publicly listed?Yes, Enlitic is a public company listed on Australian Securities Exchange.
What is the stock symbol of Enlitic?Enlitic trades under ENL ticker.
When did Enlitic go public?Enlitic went public in 2023.
Who are competitors of Enlitic?Enlitic main competitors include
What is the current market cap of Enlitic?Enlitic's current market cap is $20M.
What is the current revenue of Enlitic?Enlitic's last fiscal year revenue is $4M.
What is the current EV/Revenue multiple of Enlitic?Current revenue multiple of Enlitic is 4.8x.
Is Enlitic profitable?No, Enlitic is not profitable.
How many companies Enlitic has acquired to date?As of August 2026, Enlitic has acquired 1 company.
What was the largest acquisition by Enlitic?$5M acquisition of Laitek on 17th October 2024 was the largest M&A Enlitic has done to date.
What companies Enlitic acquired?Enlitic acquired Laitek.
In how many companies Enlitic has invested to date?Enlitic hasn't invested in any companies yet (or none have been disclosed publicly).

Lists including Enlitic

Largest Companies in the US

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial